Cover Image
市场调查报告书

腹水:全球临床实验趋势

Ascites Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品编码 237442
出版日期 内容信息 英文 87 Pages
订单完成后即时交付
价格
Back to Top
腹水:全球临床实验趋势 Ascites Global Clinical Trials Review, H1, 2017
出版日期: 2017年04月26日 内容信息: 英文 87 Pages
简介

本报告提供腹水相关之临床研究最新趋势分析,提供疾病·治疗方法概要,及G7与E7各国的临床实验状况,各地区、各期的进行状况,汇整有潜力的赞助商,各企业及研究机关的研究进行状况,有潜力的药剂比较等信息。

本报告概要

各地区的临床实验情形

  • 各国临床实验数量和平均实验人数
    • 亚太地区主要5国的临床实验数量
    • 欧洲主要5国的临床实验数量
    • 北美主要国家的临床实验数量
    • 中东·非洲主要国家的临床实验数量
    • 中南美主要国家的临床实验数量

G7各国临床实验数量:消化器官系统疾病治疗药临床实验中腹水的比例

G7各国的各阶段临床实验数量

G7各国临床实验数量:各进展状况

E7各国临床实验数量:消化器官系统疾病治疗药临床实验中腹水的比例

E7各国的各阶段临床实验数量

E7各国临床实验数量:各进展状况

各阶段临床实验数量

  • 进行中的临床实验:各阶段

各进展状况临床实验数量

临床实验的目标达成情形

一定期间所采用的实验对象

赞助商类别的临床实验数量

有潜力的赞助商

腹水治疗药临床实验参与的主要企业

有潜力的药剂

最新临床实验新闻

临床实验简介概要

附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

GlobalData's clinical trial report, "Ascites Global Clinical Trials Review, H1, 2017" provides an overview of Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Ascites to Gastrointestinal Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Ascites to Gastrointestinal Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Subjects Recruited Over a Period of Time 25
  • Clinical Trials by Sponsor Type 26
  • Prominent Sponsors 27
  • Top Companies Participating in Ascites Therapeutics Clinical Trials 29
  • Prominent Drugs 31
  • Latest Clinical Trials News on Ascites 32
  • Apr 03, 2017: BioVie Receives FDA Clearance of IND Application for Phase 2a Clinical Trial in Refractory Ascites Patients 32
  • Clinical Trial Profile Snapshots 33

Appendix 85

  • Abbreviations 85
  • Definitions 85
  • Research Methodology 86
  • Secondary Research 86
  • About GlobalData 87
  • Contact Us 87
  • Source 87

List of Tables

List of Tables

  • Ascites Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Ascites Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Ascites Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Ascites Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
  • Ascites Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Ascites Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Ascites Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Ascites Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
  • Proportion of Ascites to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 15
  • Ascites Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Ascites Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Ascites to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 18
  • Ascites Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Ascites Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Ascites Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Ascites Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Ascites Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Ascites Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Ascites Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Ascites Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
  • Ascites Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Ascites Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Ascites Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

List of Figures

List of Figures

  • Ascites Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Ascites Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Ascites Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Ascites Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
  • Ascites Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
  • Ascites Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Ascites Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
  • Ascites Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
  • Proportion of Ascites to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 15
  • Ascites Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Ascites Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Ascites to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 18
  • Ascites Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
  • Ascites Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Ascites Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
  • Ascites Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
  • Ascites Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Ascites Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
  • Ascites Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
  • Ascites Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
  • Ascites Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
  • Ascites Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Ascites Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31
  • GlobalData Methodology 86
Back to Top